item management s discussion and analysis of financial condition and results of operations overview the company is a comprehensive cancer management company 
the company provides advanced cancer treatment services through outpatient facilities known as impact r centers under the direction of practicing oncologists  owns the assets of and manages the nonmedical aspects of oncology practices  and conducts clinical cancer research on behalf of pharmaceutical manufacturers 
approximately medical oncologists are associated with the company through these programs 
in the company began development of a network of specialized impact r centers to provide complex outpatient chemotherapy services under the direction of practicing oncologists 
the majority of the therapies provided at the impact r centers entail the administration of high dose chemotherapy coupled with peripheral blood stem cell support of the patient s immune system 
at december   the company s network consisted of impact r centers  including wholly owned  managed programs  and owned and operated in joint venture with a host hospital 
prior to january  the company derived substantially all of its revenues from outpatient cancer treatment services through reimbursements from third party payors on a fee for service or discounted fee for service basis 
during the company commenced execution of a diversification strategy into practice management 
such diversification included the affiliation during with physicians in medical oncology practices in florida and tennessee 
the company has sought deep geographic penetration in those markets believing that significant market share is crucial to achieving efficiencies  revenue enhancements  and marketing of complete cancer services to diverse payors including managed care 
pursuant to service agreements  the company provides management services that extend to all nonmedical aspects of the operations of the affiliated practices 
the company is responsible for providing facilities  equipment  supplies  support personnel  and management and financial advisory services 
in its practice management relationships  the company has predominantly used two models of service agreements i an adjusted net revenue model  and ii a net operating income model 
service agreements utilizing the adjusted net revenue concept provide for the payment by the physician group out of practice net revenue  in the following order of payment a physician retainage ie physician compensation  benefits  and perquisites  including malpractice insurance of between and of net revenue physician expense  b a clinic expense portion of the management fee the clinic expense portion equal to the aggregate actual practice operating expenses exclusive of physician expense  and c a base service fee portion the base fee of between and of net revenue 
in the event that net revenue is insufficient to pay all of the foregoing in full  then the base fee is first reduced  followed by the clinic expense portion of the management fee  and finally  physician retainage  therefore effectively shifting all operating risk to the company 
in each service agreement utilizing the adjusted net revenue model  the company is entitled to a performance fee generally equal to of annual surplus  defined as the excess of practice revenue over the sum of physician retainage  the clinic expense portion  and the base fee 
service agreements utilizing the net operating income model provide for a management fee equal to the sum of a clinic expense portion see preceding paragraph plus a percentage the percentage portion  ranging from to  of the net operating income of the practice defined as net revenue minus practice operating expenses 
in those practice management relationships utilizing the net operating income model service agreement  the company and the physician group share the risk of expense increases and revenue declines  but likewise share the benefits of expense savings  economies of scale and practice enhancements 
each service agreement contains a liquidated damages provision binding the physician practice and the principals thereof in the event the service agreement is terminated for cause by the company 
the liquidated damages are a declining amount  equal in the first year to the purchase price paid by the company for practice assets and declining over a period of between and years 
principals are relieved of their individual obligations for liquidated damages only in the event of death  disability  or retirement at a predetermined age 
results of operations compared to net revenue increased to million compared to million for the year ended december  net revenue from patient services decreased 
million from million in to million in several jointly owned impact r centers became operational during that minimized the effect of the closure of three wholly owned impact r centers 
these sites were closed due to affiliations by referring physicians with another physician practice management company prior to the company establishing its own practice management alternative for oncologists 
practice management service fees from affiliations consummated beginning in january  were million or of the overall increase in net revenue 
additionally  pharmaceutical sales to physicians increased million from million in to million in practice management service fees and pharmaceutical sales to physicians both carry a lower operating margin than the company s traditional patient service revenue 
ebitda earnings before interest  taxes  depreciation and amortization increased million or to million for the year ended december   in comparison to million for the year ended december  ebitda is not intended to represent net income  cash flow  or any other measure of performance in accordance with generally accepted accounting principles  but is included because the company believes it is useful for measuring and identifying trends with respect to the company s operating performance and creditworthiness 
the increase in ebitda is primarily due to the increase in revenues related to service agreements with affiliated physicians 
operating expenses increased million  or  from million in to million in operating expenses consist primarily of payroll costs  pharmaceutical and laboratory expenses  medical director fees  rent expense  and other operational costs 
operating expenses as a percentage of net revenue were and for the years ended and  respectively 
the increase is primarily due to clinic expenses incurred at the affiliated physician practices under the service agreements 
the increase as a percentage of net revenue is due to the lower margins realized on increased practice management service fees and pharmaceutical sales to physicians 
lab and pharmacy expense  which represents the largest component of operating expenses  increased million  or  from to payroll costs increased million  or  from to the increases are primarily related to lab and pharmacy expenses and payroll costs at the affiliated physician practices that were not included in the company s operating results in general and administrative costs increased 
million  or  from million in to million in salaries and benefits  which represent the largest component of general and administrative expenses  were million in and million in the increase is primarily due to the addition of operational management personnel for the practice management division and general increases in salaries and benefits 
general and administrative costs as a percentage of net revenue were and in and  respectively 
the decrease as a percentage of net revenue is due to the significant increase in the revenue base from practice management service fees without a significant increase in general and administrative costs 
depreciation and amortization increased million from million in to million in the increase is primarily attributable to the amortization of the service agreements purchased in practice management affiliations consummated during interest expense was million in related to borrowings under the company s credit facility and debt assumed and or issued in connection with practice management affiliations 
the provision for doubtful accounts decreased 
million from million in to million in the provision as a percentage of net revenue from patient services was and for and  respectively 
the decrease is attributable to a higher proportion of contracted patient accounts 
the company s collection experience in and may not be indicative of future periods 
other costs of 
million were primarily non recurring costs associated with the company s financing efforts in tax net operating loss carryforwards were utilized to reduce income tax expense to zero 
as of december   the company had available net operating loss carryforwards totaling approximately million  all of which is subject to certain annual limitations due to a change in ownership for tax purposes in the use of net operating loss carryforwards is also dependent upon future taxable income 
see note g to the consolidated financial statements 
compared to the company recorded net earnings of million compared to a loss of million for the year ended december  the significant improvement in operations in compared to is attributable to increased revenues from the increased referrals of high dose chemotherapy patients  including the establishment of additional impact r centers  principally in joint venture with hospitals  and the further development of physician investigator studies for the pharmaceutical industry 
net revenue increased million  or  from to in addition to an approximate million increase in net revenues from services to patients to million in  sales of pharmaceuticals to physicians increased by million to million and revenues from physician investigator studies in  the first year of significant revenues generated from this source  amounted to 
million 
operating expenses increased million  or  from to operating expenses consist primarily of payroll costs  pharmaceutical and laboratory expenses  medical director fees  rent expense and other operational costs 
these expenses are expected to display a high degree of variability in proportion to center revenues 
operating expenses as a percentage of net revenue were and for the years ended and  respectively 
this decrease is primarily attributable to operating efficiencies at higher levels of center activity and certain fixed operating expenses being spread over a larger revenue base 
lab and pharmacy expense  which represents the largest component of operating expenses  increased million  or  from to the increase is primarily due to an increase in patient referrals and pharmaceutical supply expense related to sales to physicians 
a reduction in medical director fees and other operating expenses of 
million was realized during general and administrative costs increased million  or  from to salaries and benefits  which represent the largest component of general and administrative expenses  were million in and million in the increase is primarily due to management incentive compensation relative to significant improvement in operations and general increases in salaries and benefits 
general and administrative costs as a percentage of net revenue were and in and  respectively 
depreciation expense decreased 
million from to the decrease is primarily attributable to many prior capital expenditures becoming fully depreciated 
amortization expense decreased 
million from to due to the startup costs of many centers being fully amortized after a two year operational period 
the provision for doubtful accounts decreased 
million from to the provision as a percentage of net revenue was and for and  respectively 
the decrease is attributable to a higher proportion of contracted patient accounts  improved collections performance and an increase in revenues from physician sales  hospital management fees  and contract research for which collection is more certain 
the company s collection experience in and may not be indicative of future periods 
tax net operating loss carryforwards were utilized to fully offset taxable income 
liquidity and capital resources at december   the company s working capital was million with current assets of million and current liabilities of million 
cash  cash equivalents  and short term investments represented 
million of the company s current assets 
the increases in other current assets are related to receivables acquired through practice management affiliations and amounts due from affiliated physicians for practice management service fees 
current liabilities increased for amounts payable for operating expenses of practices under management and liabilities assumed as consideration in the practice management affiliations 
cash used by operating activities was million in as compared to cash provided by operating activities of million in the decrease in operating cash flow is primarily due to advances made to fund operations of recent practice management affiliations and increased general and administrative expenses in related to the company s diversification into physician practice management 
cash used by investing activities was million and million in and  respectively 
the increase primarily represents funds used to acquire the nonmedical assets of the physician practices 
cash provided by financing activities was million in and 
million in the increase in primarily represents proceeds from borrowings under the company s acquisition facility and from seafield capital corporation seafield to finance practice management affiliations 
in april  the company obtained an unsecured million loan the seafield note from seafield bearing interest at the rate of prime plus  which after august   became convertible at the election of seafield into shares of the company s common stock 
proceeds of the loan were used to finance a practice management affiliation 
the loan was exchanged for  shares of common stock during august  in may  the company entered into a million credit facility with nationsbank and union planters to fund the company s acquisition and working capital needs and to repay its existing facility with union planters 
the credit facility  comprised of a million acquisition facility and a million working capital facility  is collateralized by the common stock of the company s subsidiaries 
the acquisition facility matures may   and bears interest at a variable rate equal to libor plus a spread between and  depending upon borrowing levels 
the working capital facility matures may   subject to a one year extension  and bears interest at a variable rate equal to libor plus a spread between and 
at december   million aggregate principal was outstanding under the credit facility with a current interest rate of approximately 
the company s available credit under the credit facility at december  was 
million 
the credit facility contains affirmative and negative covenants which  among other things  require the company to maintain certain financial ratios  including minimum fixed charges coverage  funded debt to ebitda  net worth and current ratio 
as of december   the company was in compliance with the covenants included in the credit facility 
the company has received a commitment to increase the credit facility to million 
the company anticipates that working capital generated from operations and anticipated availability under the credit facility will be adequate to expand the impact r center network  manage the practices with which the company has affiliated  and to make certain strategic acquisitions for the next months 
the company s acquisition strategy is dependent upon capital resources in excess of working capital generated from operations and currently available credit facilities 
additionally  long term unsecured  amortizing  promissory notes bearing interest at rates from to were issued as partial consideration for the practice management affiliations 
principal and interest under the long term notes may  at the election of the holders  be paid in shares of common stock of the company based upon conversion rates ranging from to 
the unpaid principal amount of the long term notes was million at december in october  the company procured a million credit facility from seafield the seafield facility to finance acquisitions and for working capital 
at december   million was outstanding under the seafield facility at an interest rate of 
on february   the million loan and accrued interest of 
million was exchanged for  shares of the company s common stock at a rate of per share which exchange rate was above the quoted market price of the common stock at the date of conversion 
simultaneous with the conversion  seafield announced its intention to consider a distribution to its shareholders in of seafield s shares of the company s common stock 
on july   the company filed a registration statement with the securities and exchange commission with respect to the public offering of million shares of its common stock  
par value per share 
because of market conditions subsequent to filing  the company chose not to pursue the public offering and sought acquisition financing from the aforementioned sources 
the registration statement has not been withdrawn and could be utilized in connection with any distribution by seafield  if made 
capital expenditures of million for the year ended december   were primarily associated with the expansion of the company s network of impact r centers 
no material commitments for capital expenditures currently exist 
the company is committed to future minimum lease payments under operating leases of million for administrative and operational facilities 
new accounting standards the financial accounting standards board has issued statement of financial accounting standards no 
sfas  earnings per share  and statement of financial accounting standards no 
sfas  disclosure of information about capital structure 
sfas establishes standards for computing and presenting earnings per share and applies to entities with publicly held common stock 
sfas establishes standards for disclosing information about an entity s capital structure and applies to all entities 
management believes that the company s adoption of these standards  when effective  will not have a significant impact on the company s financial statements 

